Daiichi Sankyo
Usha Kidambi is a seasoned professional with extensive experience in global project management and leadership within the pharmaceutical industry. Currently serving as Senior Director at Daiichi Sankyo, Inc., Usha leads late-stage oncology projects and has successfully managed a Global Transformation initiative. Previous roles include Directorships at Dr. Reddy's Laboratories, focusing on development and technical alliances, and strategy in biologics product development. Usha's career also includes significant contributions at Otsuka Pharmaceutical and Merck, where key achievements encompassed steering product development teams and managing novel drug initiatives across various therapeutic areas. Usha holds a Bachelor's degree in Biochemistry from Rutgers University and a joint Master's degree in Biochemistry from the University of Medicine and Dentistry of New Jersey and Rutgers University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.